PTGX icon

Protagonist Therapeutics (PTGX)

NASDAQ

$92.17

$3.74 (

+4.23%

)

1D
5D
1M
6M
1Y
5Y
Market closed

PTGX: $92.17 / ₿ 0.0014 BTC / 138976 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$88.43
$37.20 - $96.54
$5.76B
10.32
$88.85
$936,969.27
62.52M
139.65
$83.00 - $94.96
$87.58 - $92.21
Yes

What is Protagonist Therapeutics (PTGX)?

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

The Protagonist Therapeutics (PTGX) stock price has been rising

The Protagonist Therapeutics, Inc. Common Stock (PTGX) stock price today is $92.17, reflecting a +4.23% move since the market opened. The company’s market capitalization stands at $5.76B, with a daily trading volume of $936.97K shares. For investors tracking price trends, Protagonist Therapeutics, Inc. Common Stock stock has ranged between $87.58 and $92.21 today. The previous closing price was $88.43.

Get started with Protagonist Therapeutics (PTGX)

Ready to get started? Follow the steps below, or read our guide on how to buy Protagonist Therapeutics stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy PTGX

Search for PTGX in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy PTGX.

PTGX FAQs

PTGX is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

PTGX is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Protagonist Therapeutics, Inc. Common Stock (PTGX) has traded between a low of $37.20 and a high of $96.54.

PTGX is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Protagonist Therapeutics? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
PTGX icon
PTGX

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Protagonist Therapeutics in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

OTRKQ icon

OTRKQ

YOTAR icon

YOTAR

CRESW icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.